Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Deep Learning Model for the Prediction of Hepatocellular Cancer Recurrence After Transplantation: The Time-Radiological Response- AlphafetoproteIN-Artificial Intelligence Model

NCT05200195 is registered in ClinicalTrials.gov with European Hepatocellular Cancer Liver Transplant Group as lead sponsor.

NCT NCT05200195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05200195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Deep Learning Model for the Prediction of Hepatocellular Cancer Recurrence After Transplantation: The Time-Radiological Response- AlphafetoproteIN-Artificial Intelligence Model
Lead sponsor
European Hepatocellular Cancer Liver Transplant Group
Phase
Observational
Overall status
Completed
Start date
January 15, 2020
Completion date
March 15, 2022
Enrollment
4,026 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, liver transplant disorder, recurrent cancer